The incidence of primary colorectal lymphoma is very rare, accounting for 0.2%--0.6% of colorectal malignancies \[[@b1-jptm-2019-07-12]\]. Primary colorectal lymphomas manifest in a variety of ways, ranging from solitary fungating masses to multiple polyps. In 1968, Friedman et al. \[[@b2-jptm-2019-07-12]\] reported four cases of "lymphomatous colitis," a rare form of primary colorectal lymphoma mimicking ulcerative colitis (UC). Since then, a small number of patients with diffuse-type colorectal lymphoma have been reported, in whom a clinical and/or histological diagnosis of colitis, including inflammatory bowel disease (IBD), was made initially but were subsequently discovered to have diffuse lymphoma involvement of the colon within a short period of time \[[@b3-jptm-2019-07-12]-[@b17-jptm-2019-07-12]\]. IBD and immunosuppression have been reported as risk factors for primary colorectal lymphoma \[[@b18-jptm-2019-07-12]\]. Most IBD-related lymphomas develop late in the course of an extensive longstanding disease. In that respect, these cases differ from most reports of primary colorectal lymphoma as a complication of longstanding IBD. We experienced a case of UC-like primary colorectal lymphoma in a 31-year-old woman who presented with profuse hematochezia, was misdiagnosed with UC, and died of a diffuse lymphoma involving the entire colon 12 months after hematochezia first developed.

CASE REPORT
===========

A 31-year-old woman with no prior history of IBD presented with intermittent abdominal pain and mucoid diarrhea. Five months later, she developed hematochezia and was diagnosed with UC on the basis of endoscopic biopsy. She was treated with oral Pentasa and Pentasa enema. However, she continued to be symptomatic with marked weight loss (20 kg in 4 months). Follow-up colonoscopy revealed continuous mucosal changes from the rectum to the cecum, such as diffuse hyperemia, edematous changes, friability, loss of normal vascularity, and multiple variable-sized ulcers, consistent with UC ([Fig. 1A](#f1-jptm-2019-07-12){ref-type="fig"}). No mass-forming lesion was present throughout. Abdominal and pelvic computed tomography revealed diffuse edematous wall thickening in the whole colon and multiple enlargements of mesenteric lymph nodes. No hepatosplenomegaly was observed. Multiple biopsies were taken from the terminal ileum, cecum, transverse colon, sigmoid colon, and rectum. All biopsy specimens revealed diffuse infiltration of large, atypical lymphoid cells with a high nucleus-to-cytoplasmic ratio, occasional prominent nucleoli, and mitotic figures ([Fig. 1B](#f1-jptm-2019-07-12){ref-type="fig"}, [C](#f1-jptm-2019-07-12){ref-type="fig"}). They expanded the lamina propria, pushed the crypts apart, and invaded the submucosa. By immunochemistry, the tumor cells were diffusely positive for CD20, bcl2, and p53, and negative for CD3, CD5, CD10, and cyclin D1. The Ki-67 labeling index was about 60%. The overall histology and immunophenotype supported a diagnosis of diffuse large B-cell lymphoma. There was no detectable evidence of extra-abdominal lymphadenopathy or lymphomatous involvement elsewhere. Bone marrow evaluation was also negative for lymphoma. As no extraintestinal disease was found, we considered it as a primary colorectal lymphoma. The patient died while receiving the second cycle of R-CHOP chemotherapy.

We retrospectively reviewed the colonoscopic biopsy specimens that were initially diagnosed with UC. At low magnification view, the background mucosa displayed crypt architectural distortion and dense inflammatory cell infiltration, resembling chronic colitis. However, we found some lymphoma cells, which were admixed with other inflammatory cells or showed focal aggregation in the basal portion of the mucosa ([Fig. 1D](#f1-jptm-2019-07-12){ref-type="fig"}). Those lymphoma cells were more distinguishable on immunostaining for CD20 and Ki-67 ([Fig. 1E](#f1-jptm-2019-07-12){ref-type="fig"}, [F](#f1-jptm-2019-07-12){ref-type="fig"}).
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DISCUSSION
==========

Twenty cases (including the present one) of "colitis-like" diffuse-type colorectal lymphoma were reported in the English literature \[[@b2-jptm-2019-07-12]-[@b17-jptm-2019-07-12]\]. We excluded cases of colorectal lymphoma developed in patients with a longstanding IBD or prior established diagnosis of extracolonic lymphoma. The clinical and pathological findings of these patients are summarized in [Table 1](#t1-jptm-2019-07-12){ref-type="table"}. There were 10 men, 8 women, and two children. Their mean age at presentation was 53.2 years (range, 6 to 82 years). The main symptoms were diarrhea/hematochezia (90%), loss of weight (50%), abdominal pain (25%), and fever (10%). Endoscopic findings were consistent with UC (55%), Crohn disease (20%), diffuse colitis (20%), and multiple ulcers (5%): no localized mass-like lesion was present. All cases were non-Hodgkin's lymphoma: eight were B-cell type (four mantle cell lymphomas, two mucosa-associated lymphoid tissue lymphomas, one diffuse large B-cell lymphoma, and one follicular lymphoma), seven were T-cell type, one was natural killer cell lymphoma, and four other unclassified lymphoreticular malignancies (one malignant lymphoma, one reticulum cell sarcoma, one lymphosarcoma, and one lymphocytic lymphoma). Of note, there were nine patients in whom colitis was histologically confirmed with multiple biopsy or colectomy but were subsequently found to have lymphoma involvement in a retrospective review of previous slides. Taken together, diffuse type primary colorectal lymphoma is a very rare disease and is easily misdiagnosed, particularly in reliance on endoscopic biopsy examination alone. The possibility of a hidden lymphomatous involvement would have to be considered in patients with medically refractory and rapidly progressive colitis.

Lymphoma involvement of the gastrointestinal (GI) tract may occur either as an isolated primary neoplasm or as a manifestation of systemic generalized lymphoma. To distinguish between primary and secondary GI lymphoma, Dawson's criteria is generally applied: (1) no palpable superficial lymphadenopathy at initial presentation, (2) a normal chest X-ray with no mediastinal lymphadenopathy, (3) no evidence of leukemia, (4) a predominant mass in the bowel with only local lymphadenopathy, and (5) no hepatosplenomegaly \[[@b19-jptm-2019-07-12]\]. When the diagnostic criteria of primary colonic lymphoma are strictly applied, only seven of 20 cases of "colitis-like" colorectal lymphoma are eligible for diffuse-type primary colorectal lymphoma: 13 cases were excluded due to synchronous other organ involvement at initial presentation, such as superficial or generalized lymphadenopathy (six cases), upper GI involvement (five cases), bone marrow involvement (four cases), or hepatosplenomegaly (three cases), etc. Consequently, it is a reflection that "colitis-like" diffuse involvement of colorectal lymphoma seems to be more often secondary. Accurate discrimination between primary and secondary colorectal lymphoma is important for proper staging and management. In conclusion, since primary colorectal lymphoma can rarely manifest as "colitis-like" diffuse colonic involvement, awareness of this rare presentation is important to ensure proper diagnosis and treatment.
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![(A) Colonoscopy reveals diffuse hyperemic inflamed mucosa with total loss of normal vascularity and surface ulceration from the rectum to the cecum. (B, C) Representative microphotographs of diffuse lymphoma involvement on the biopsy specimens. (B) The mucosa and submucosa are diffusely involved by densely packed lymphocytes with the background remnants of colonic crypts. Monotonous large-sized lymphocytes have vesicular chromatin and often membrane-bound nucleoli, resembling centroblasts (C). (D--F) Retrospective examination of initial colonoscopic biopsy. (D) The biopsied colonic mucosa displays crypt architectural distortion and dense inflammatory cell infiltration, resembling chronic colitis. Atypical lymphoid cells are aggregated in the bottom right corner (below the yellow dotted line), which show not only strong expression on CD20 immunostaining (E) but also high Ki-67 labeling index (F).](jptm-2019-07-12f1){#f1-jptm-2019-07-12}

###### 

Clinical and pathological findings of previously published cases of "colitis-like" diffuse-type colorectal lymphomas in the English literature

  Year   Author                                           Sex/Age (yr)   Pathologic diagnosis             Endoscopic findings   Revision of initial diagnosis   Superficial LAP at presentation   Extracolonic involvement
  ------ ------------------------------------------------ -------------- -------------------------------- --------------------- ------------------------------- --------------------------------- --------------------------
  1968   Friedman et al. \[[@b2-jptm-2019-07-12]\]        M/37           Reticulum cell sarcoma           UC                    No                              No                                Liver
  1968   Friedman et al. \[[@b2-jptm-2019-07-12]\]        F/54           Malignant lymphoma               UC                    Yes (colectomy)                 No                                No
  1968   Friedman et al. \[[@b2-jptm-2019-07-12]\]        M/73           Lymphosarcoma                    UC                    Yes (Bx)                        No                                No
  1980   Weir et al. \[[@b3-jptm-2019-07-12]\]            F/67           Lymphocytic lymphoma             CD                    Yes (Bx)                        Yes, generalized                  BM
  1992   McCullough et al. \[[@b4-jptm-2019-07-12]\]      M/44           Mantle cell lymphoma             UC                    Yes (Bx)                        Yes, cervical axillary            Pancreas
  1995   Lenzen et al. \[[@b5-jptm-2019-07-12]\]          F/53           MALT lymphoma                    UC                    No                              No                                Upper GI tract, BM
  1996   Robert et al. \[[@b6-jptm-2019-07-12]\]          F/71           Mantle cell lymphoma             UC                    Yes (colectomy)                 No                                No
  1996   Hirakawa et al. \[[@b7-jptm-2019-07-12]\]        M/47           T-cell lymphoma                  UC                    No                              No                                Upper GI tract
  1997   Son et al. \[[@b8-jptm-2019-07-12]\]             F/40           Peripheral T-cell lymphoma       CD                    Yes (Bx)                        No                                No
  2003   Isomoto et al. \[[@b9-jptm-2019-07-12]\]         M/47           Adult T-cell leukemia/lymphoma   UC                    No                              Yes, generalized                  Stomach, skin
  2004   Payne et al. \[[@b10-jptm-2019-07-12]\]          F/76           High-grade T-cell lymphoma       Colitis               No                              Yes, generalized                  No
  2004   Tamura et al. \[[@b11-jptm-2019-07-12]\]         M/61           Mantle cell lymphoma             Colitis               No                              No                                Tonsil, upper GI tract
  2008   Berkelhammer et al. \[[@b12-jptm-2019-07-12]\]   F/82           MALT lymphoma                    CD                    Yes (Bx)                        No                                No
  2014   Koksal et al. \[[@b13-jptm-2019-07-12]\]         M/73           Mantle cell lymphoma             UC                    No                              No                                Stomach
  2015   Zaheen et al. \[[@b14-jptm-2019-07-12]\]         M/74           EBV-negative NK cell lymphoma    Colitis               No                              No                                BM, pleural effusion
  2015   Wu et al. \[[@b15-jptm-2019-07-12]\]             M/56           T-cell lymphoma                  Ulcers                Yes (Bx)                        Yes, generalized                  No
  2016   Cheung et al. \[[@b16-jptm-2019-07-12]\]         NA/12          EBV-positive T-cell lymphoma     Colitis               No                              No                                Hepatosplenomegaly
  2016   Cheung et al. \[[@b16-jptm-2019-07-12]\]         NA/6           EBV-positive T-cell lymphoma     CD                    No                              No                                No
  2017   Zenda et al. \[[@b17-jptm-2019-07-12]\]          M/59           Follicular lymphoma              UC                    No                              Yes, cervical inguinal            Spleen, BM
         Present case                                     F/32           Diffuse large B-cell lymphoma    UC                    Yes (Bx)                        No                                No

LAP, lymphadenopathy; M, male; UC, ulcerative colitis; F, female; Bx, biopsy; CD, Crohn's disease; BM, bone marrow; MALT, mucosa-associated lymphoid tissue; GI, gastrointestinal; EBV, Epstein-Barr virus; NA, not available.
